Celularity CELU
NASDAQ CELU
$1.60 +0.22 (+15.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Celularity (CELU) Asset Writedowns and Impairment (2020 - 2025)

Updated

Celularity (CELU) posted Asset Writedowns and Impairment of $2.89 million for FY2025.

Analysis

Celularity (CELU) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends

Since FY2020, Celularity has reported Asset Writedowns and Impairment for 4 years.

  • Annual Asset Writedowns and Impairment shows a five-year compound annual growth rate of -53.2% (FY2020 to FY2025).
  • Business Quant data shows CELU's Asset Writedowns and Impairment at $112.35 million in FY2023 and $3.61 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Celularity 46.69 Mn 39.16 Mn 2.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -123,000.00
Sep 30, 2023 82.71 Mn
Mar 31, 2023 29.63 Mn
Dec 31, 2022 3.61 Mn
Sep 30, 2020 129.40 Mn
API Access

Celularity Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=CELU&period=max&api_key=YOUR_API_KEY